-
Severe complications of tramadol overdose in Iran
-
Paria Habibollahi, Alireza Garjani, Samad Shams Vahdati, Seyyed-Reza Sadat-Ebrahimi, Neda Parnianfard
-
Epidemiol Health. 2019;41:e2019026. Published online June 16, 2019
-
DOI: https://doi.org/10.4178/epih.e2019026
-
-
19,584
View
-
274
Download
-
11
Web of Science
-
13
Crossref
-
 Abstract
 PDF
-
Abstract
OBJECTIVES
Severe complications of tramadol overdose have been reported; however, few large-scale studies have investigated this issue. Therefore, this study aimed to explore the presentation and complications of tramadol overdose in patients admitted to an intoxication referral center in northwestern Iran.
METHODS Patients with tramadol overdose admitted to Sina Teaching Hospital in Tabriz, Iran during 2013-2017 were included. For each patient, the following data were collected: demographics, previous drug or medication overdose, whether the patient was in the process of quitting drug use, ingested dose of tramadol and co-ingestants, Glasgow Coma Scale (GCS) score, clinical symptoms at the time of admission, and admission characteristics. Serotonin toxicity was diagnosed in patients who fit the Hunter criteria. Multiple logistic regression was performed to identify variables associated with the incidence of severe complications of tramadol overdose.
RESULTS In total, 512 cases of tramadol overdose were evaluated, of which 359 patients were included, with a median age of 41 years (range, 16-69) and a median tramadol dose of 1,500 mg (range, 500-4,000). The most frequent complications associated with tramadol overdose were hypertension (38.4%), tachycardia (24.8%), and seizure (14.5%). No serotonin toxicity was detected in patients. Having a GCS score <15, having taken a tramadol dose of >1,000 mg, being in the process of quitting drug use, being 30-49 years old, and male sex were significantly related to the incidence of severe complications of tramadol overdose.
CONCLUSIONS Although seizure was prevalent among Iranian patients with tramadol poisoning, serotonin toxicity and cardiogenic shock were rare findings.
-
Summary
-
Citations
Citations to this article as recorded by  - Sex-Gender Differences Are Completely Neglected in Treatments for Neuropathic Pain
Francesco Salis, Salvatore Sardo, Gabriele Finco, Gian Luigi Gessa, Flavia Franconi, Roberta Agabio
Pharmaceuticals.2024; 17(7): 838. CrossRef - Investigation of clinical and paraclinical consequences of tramadol poisoning and related factors
Pantea Ramezannezhad, Mahmoud Hashemzaei, Zohreh Pajohesh, Khadijeh Saravani, Omid Bameri
Journal of Shahrekord University of Medical Sciences.2024; 26(3): 132. CrossRef - Tramadol Abuse-associated Seizure: An Epidemiological and Electroencephalographic Study
Farhad Iranmanesh, Hamide Arvan, Habibeh Ahmadipour, Faranak Gadari, Hussien Barzegar, Mahdiyeh Khazaneha
International Journal of High Risk Behaviors and Addiction.2023;[Epub] CrossRef - Clinical and Laboratory Factors Related to Seizure and Serotonin Toxicity in Tramadol Intoxication: An Egyptian Study
Ahmed Amin Ali, Mahmoud Mohamed Abdeshafy, Khaled Abdelkawy, Ramy M. Elsabaa, Fawzy Elbarbry
Clinical Drug Investigation.2023; 43(12): 963. CrossRef - Lower uric acid and adequate hydration are associated with lower risk of febrile neutropenia following autologous bone marrow transplantation in patients with lymphoma
Babak Nejati, Zohreh Kourehpaz, Roya Dolatkhah, Mojtaba Varshochi, Maryam Farmani, Alireza Parviz
Journal of Medical Science.2023; 92(4): e836. CrossRef - Increase of high‐risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data
Anne Roussin, Thomas Soeiro, Charlotte Fouque, Emilie Jouanjus, Elisabeth Frauger, Nathalie Fouilhé, Michel Mallaret, Joëlle Micallef, Maryse Lapeyre‐Mestre
British Journal of Clinical Pharmacology.2022; 88(8): 3789. CrossRef - Determination of Tramadol and Fluoxetine in Biological and Water Samples by Magnetic Dispersive Solid-Phase Microextraction (MDSPME) with Gas Chromatography – Mass Spectrometry (GC-MS)
Banafsheh Sefaty, Mahboubeh Masrournia, Zarrin Es’haghi, Mohammad Reza Bozorgmehr
Analytical Letters.2021; 54(5): 884. CrossRef - Machine learning algorithms to predict seizure due to acute tramadol poisoning
B Behnoush, E Bazmi, SH Nazari, S Khodakarim, MA Looha, H Soori
Human & Experimental Toxicology.2021; 40(8): 1225. CrossRef - Factors Associated with Tramadol Abuse: A Cross-Sectional Study Among Commercial Drivers and Assistants in the Accra Metropolitan Area of Ghana
Mavis Danso, Francis Anto
Drugs - Real World Outcomes.2021; 8(3): 337. CrossRef - Evaluation of mitochondrial dysfunction due to oxidative stress in therapeutic, toxic and lethal concentrations of tramadol
Leila Mohammadnejad, Kambiz Soltaninejad, Mohammad Seyedabadi, Seyed Khosro Ghasem Pouri, Mohammad Shokrzadeh, Hamidreza Mohammadi
Toxicology Research.2021; 10(6): 1162. CrossRef - Rapport de cas d’un choc cardiogénique et syndrome sérotoninergique sur une synergie entre tramadol et venlafaxine
G. Barthélemy, D. Gusu, D. Glorieux
Journal Européen des Urgences et de Réanimation.2021; 33(4): 201. CrossRef - Therapeutic levels of short-term tramadol administration negatively affect testis function in rats
Jonah Sydney Aprioku, Benjamin Toochukwu Okpe, Doupere Ben
Asian Pacific Journal of Reproduction.2021; 10(1): 29. CrossRef - Drug utilization review of tramadol hydrochloride in a regional hospital in South Africa; findings and implications
Akhona Fynn, Elvera Helberg, Brian Godman, Johanna C Meyer
Hospital Practice.2020; 48(2): 92. CrossRef
|
KSE
